BharatNotes What is Bioeconomy?
Bioeconomy comprises all economic activity that draws on renewable biological resources — crops, forests, marine life, animals, micro-organisms and organic waste — and converts them, often using biotechnology, into food, feed, bio-based chemicals, materials, pharmaceuticals and bioenergy. The European Commission frames it as "the production of renewable biological resources and the conversion of these resources and waste streams into value-added products". It is a cornerstone of the circular economy and of green growth, because it replaces fossil-based inputs with renewable, lower-carbon alternatives.
Why It Matters
- Decarbonisation: Bio-based chemicals, biofuels and bioplastics reduce dependence on petroleum and support net-zero goals.
- Health security: Vaccines, biotherapeutics and diagnostics — a strength India demonstrated during COVID-19.
- Rural and agri value-addition: Turns agricultural residue and biomass into higher-value products and jobs.
- Strategic self-reliance: Smart proteins, enzymes and biomanufacturing reduce import dependence (aligned with Atmanirbhar Bharat).
India's Bioeconomy: Current Status
India's bioeconomy has grown roughly sixteen-fold, from about $10 billion in 2014 to $165.7 billion in 2024, contributing 4.25% of GDP (India BioEconomy Report 2025, BIRAC/ABLE; GDP base ~$3.89 trillion). A subsequent estimate placed it at about $195 billion in 2025 (~4.8% of GDP) (IBER 2026 figures, reported 2026). The roadmap targets $300 billion by 2030 and $1 trillion by 2047.
| Indicator | Value (as of IBER 2025, data year 2024) |
|---|---|
| Total bioeconomy value | ~$165.7 billion |
| Share of GDP | 4.25% |
| BioIndustrial (biofuels, chemicals, bioplastics, enzymes) | ~$78.2 billion (~48%) |
| BioPharma (vaccines, biologics) | ~$58.4 billion (~35%) |
| Number of companies | ~10,075 (up from 5,365 in 2021) |
| 2030 target | $300 billion |
| 2047 target | $1 trillion |
Maharashtra, Karnataka and Telangana are the leading state contributors (IBER 2025).
The BioE3 Policy (2024)
The BioE3 Policy — Biotechnology for Economy, Environment and Employment was approved by the Union Cabinet on 24 August 2024 by the Department of Biotechnology. It seeks to foster high-performance biomanufacturing through:
- Innovation-driven R&D and entrepreneurship support.
- Setting up Biomanufacturing & Bio-AI hubs and Biofoundries.
- Six strategic sectors: high-value bio-based chemicals, biopolymers and enzymes; smart proteins and functional foods; precision biotherapeutics; climate-resilient agriculture; carbon capture and utilisation; and marine and space research.
The policy explicitly advances a circular bioeconomy, supporting India's Net Zero and LiFE (Lifestyle for Environment) commitments. Its financial outlay of ₹9,197 crore is provided under the 15th Finance Commission period (2021-22 to 2025-26).
UPSC Angle
Treat bioeconomy as a connector topic linking biotechnology (GS3 S&T), the circular economy, and sustainable development. For Mains, be able to argue how the BioE3 Policy operationalises green growth and job creation; for Prelims, retain the BioE3 features, the IBER headline figures, and the distinction between bioindustrial and biopharma segments. Cross-link with ethanol blending, bioplastics rules, and the National Biofuels Policy for a fuller answer.
